PharmaShots | Incisive News in 3 Shots

Subscribe Now

Geron

Geron’s Rytelo (Imetelstat) Gains the US FDA’s Approval to Treat Myelodysplastic Syndromes (MDS) with Transfusion-Dependent Anemia

Geron’s Rytelo (Imetelstat) Gains the US FDA’s Approval to Treat Myelodysplastic Syndromes (MDS) with Transfusion-Dependent Anemia

June 7, 2024

Geron Report EMA’s Validation of MAA for Imetelstat to Treat Transfusion-Dependent Anemia in Patients with Lower Risk Myelodysplastic Syndromes

Geron Report EMA’s Validation of MAA for Imetelstat to Treat Transfusion-Dependent Anemia in Patients with Lower Risk Myelodysplas...

September 29, 2023

Geron Reports the US FDA Acceptance of NDA for Imetelstat to Treat Transfusion-Dependent Anemia in patients with Lower Risk Myelodysplastic Syndromes

Geron Reports the US FDA Acceptance of NDA for Imetelstat to Treat Transfusion-Dependent Anemia in patients with Lower Risk Myelod...

August 21, 2023

Top Biopharma Deal Terminations of 2018-2019 by Total Value Received

Top Biopharma Deal Terminations of 2018-2019 by Total Value Received

January 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us